| Literature DB >> 32179804 |
Se Hyun Choi1,2, Mee Kum Kim2,3, Joo Youn Oh4,5.
Abstract
Effects of chemical injuries on the cornea and limbus have been widely studied; however, little is known about glaucoma after ocular chemical injuries. We herein investigated the incidence, risk factors, and outcome of glaucoma in patients with ocular chemical burns. Medical records were reviewed of patients who visited our clinic for chemical injuries to the ocular surface. Patients were divided into glaucoma and non-glaucoma groups based on high intraocular pressure (IOP) readings. Clinical characteristics, treatment method, and therapeutic and visual outcomes were compared between the two groups. Of 29 patients (40 eyes), 9 patients (15 eyes, 37.5%) were diagnosed with glaucoma at 2.64 ± 2.92 months after injury. Factors associated with glaucoma included male gender (p = 0.0114), bilateral ocular involvement (p = 0.0478), severe ocular surface involvement (Dua grades IV-VI, p = 0.0180), poor initial visual acuity (p = 0.0136), high initial IOP (p < 0.0001), pupil involvement at initial examination (p = 0.0051), and the need for amniotic membrane transplantation in the acute stage (p = 0.0079). At final follow-up, IOP was uncontrolled in 3 eyes (20.0%), and visual acuity was worse in the glaucoma group than in the non-glaucoma group (logMAR 2.94 ± 1.86 vs 0.34 ± 0.69, p < 0.0001). These findings suggest that careful evaluation and intensive treatment for glaucoma are essential in patients with severe ocular burns.Entities:
Mesh:
Year: 2020 PMID: 32179804 PMCID: PMC7076008 DOI: 10.1038/s41598-020-61822-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics, clinical characteristics, and burn management.
| Total | Glaucoma group | Non-glaucoma group | ||
|---|---|---|---|---|
| No. of patients (eyes) | 29 (40) | 9 (15) | 20 (25) | |
| Age (years, range) | 43.0 ± 14.8 | 41.3 ± 18.0 | 43.8 ± 13.6 | 0.8502 |
| (20–65) | (20–65) | (22–62) | ||
| Sex (male:female) | 19:10 | 9:0 | 10:10 | 0.0114 |
| Laterality (unilateral:bilateral) | 18:11 | 3:6 | 15:5 | 0.0478 |
| Insulting agent (acid:alkali:unknown) | 11:16:2 | 4:4:1 | 7:12:1 | 0.6754 |
| Follow-up period (months, range) | 41.5 ± 47.7 | 69.9 ± 62.9 | 28.7 ± 33.8 | 0.0981 |
| (1–185) | (1–185) | (1–129) | ||
| Ocular burn severity | ||||
| Dua grade | ||||
| Low (I–III) | 24 | 5 | 19 | 0.0180 |
| High (IV–VI) | 16 | 10 | 6 | |
| Roper Hall grade | ||||
| Low (I–II) | 17 | 4 | 13 | 0.1874 |
| High (III–IV) | 23 | 11 | 12 | |
| Initial visual acuity (logMAR) | 1.13 ± 1.07 | 1.63 ± 1.23 | 0.82 ± 0.85 | 0.0136 |
| Initial IOP (mmHg) | 20.9 ± 10.9 | 31.8 ± 10.9 | 14.7 ± 3.8 | <0.0001 |
| Initial IOP (normal:increased) | 27:12 | 3:11 | 24:1 | <0.0001 |
| Corneal epithelial defect (No:Yes) | 9:30 | 3:11 | 6:19 | 1.0000 |
| Pupil involvement (No:Yes) | 32:7 | 8:6 | 24:1 | 0.0051 |
| IV steroid | 2 | 2 | 0 | 0.0887 |
| Topical corticosteroids | 13 | 4 | 9 | 1.0000 |
| Systemic steroid (IV and/or oral) | 15 | 6 | 9 | 0.4270 |
| Oral doxycycline | 26 | 8 | 18 | 1.0000 |
| Oral vitamin C | 26 | 7 | 19 | 0.2200 |
| Therapeutic contact lens | 11:28 | 5:9 | 6:19 | 0.4780 |
| Autologous serum eye drops | 16:23 | 4:10 | 12:13 | 0.3171 |
| AMT (No:Yes) | 20:20 | 3:12 | 17:8 | 0.0079 |
| Penetrating keratoplasty (No:Yes) | 29:11 | 7:8 | 22:3 | 0.0090 |
| Limbal allogeneic graft (No:Yes) | 31:9 | 8:7 | 23:2 | 0.0077 |
| Buccal mucosa autograft (No:Yes) | 35:5 | 12:3 | 23:2 | 0.3446 |
| Eyelid surgery (No:Yes) | 37:3 | 12:3 | 25:0 | 0.0461 |
logMAR: logarithm of the Minimum Angle of Resolution, IOP: intraocular pressure, IV: intravenous, AMT: amniotic membrane transplantation.
Logistic regression analysis of risk factors for glaucoma development.
| Odds ratio | Confidence interval (95%) | ||
|---|---|---|---|
| Increased IOP | 151.247 | 8.508–2688.612 | 0.001 |
| Pupil involvement | 43.413 | 1.971–956.331 | 0.017 |
| Ocular burn severity | 0.444 | ||
| Initial Visual Acuity | 0.555 | ||
| Corneal epithelial defect | 0.872 | ||
| Sex | 0.312 | ||
| Age | 0.993 | ||
| Laterality (unilateral or bilateral) | 0.088 | ||
| Insulting agent (acid or alkali) | 0.299 | ||
| Systemic steroid (IV and/or oral) | 0.394 | ||
| Oral doxycycline | 0.615 | ||
| Oral vitamin C | 0.507 | ||
| Therapeutic contact lens | 0.983 | ||
| Autologous serum eye drops | 0.759 | ||
Figure 1Survival curves from Cox regression analysis to determine the time from ocular chemical injury to glaucoma diagnosis. (A) During 6 months of follow-up, glaucoma developed in approximately 10% of patients who had normal intraocular pressures (IOP) at initial examination after injury, whereas glaucoma occurred in over 70% of patients whose IOP elevated to >21 mmHg at initial evaluation (p < 0.0001, B = 2.603). (B) Glaucoma developed in 85.7% of eyes (6 of 7) showing pupil involvement at initial examination and in 25.0% of eyes (8 of 32) without the initial pupil involvement. The time to glaucoma diagnosis was not different between eyes with and without pupil involvement (p = 0.189).
Glaucoma management.
| No. (%) | Duration (days) | |
|---|---|---|
| Intravenous mannitol | 5 (55. 6) | |
| Oral acetazolamide | 7 (77.8) | 536 ± 1134 |
| β-blockers | 11 (73.3) | 940 ± 1359 |
| Prostaglandin analogues | 11 (73.3) | 237 ± 475 |
| α2-adrenergic agonists | 14 (93.3) | 885 ± 1180 |
| Carbonic anhydrase inhibitors | 10 (66.7) | 755 ± 972 |
| Ahmed valve implantation | 4 (26.7) | 21.0 ± 20.9 months (7, 10, 15, 52 months post-injury) |
Figure 2The final visual outcome in patients with ocular chemical burns according to the presence of glaucoma. The logarithm of the Minimum Angle of Resolution (logMAR) visual acuities were significantly poorer in eyes developing glaucoma than in those without glaucoma (p < 0.0001).